RecruitingNot ApplicableNCT03859050

Alveolar Macrophage Programming Following Endotoxin Exposure


Sponsor

National Jewish Health

Enrollment

25 participants

Start Date

Mar 18, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

The histologic hallmarks of lung inflammation include accumulation of inflammatory cells in the airspaces and interstitium, injury to alveolar epithelial and endothelial cells, loss of epithelial-capillary integrity and accumulation of edema fluid in the interstitium and airspaces. Accordingly, for alveolar repair to occur inflammation must be halted, debris and inflammatory cells removed, injured tissue cells replaced, and capillary barrier function re-established. Macrophages are key players in all of these. Here the investigators hypothesize that resident alveolar macrophages and recruited macrophages serve completely different functions, acting independently (i.e. division of labor) yet cooperatively (synergism).


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Inclusion Criteria2

  • Written, informed consent
  • Age 18-50

Exclusion Criteria10

  • Current or recent illness (past 2 weeks)
  • Presence or prior history of cardiac, pulmonary or systemic disease
  • Bleeding disorder, use of systemic anticoagulants or antiplatelet therapy
  • American Society of Anesthesiology (ASA) class 2 or greater
  • Immunocompromised state (HIV, immunoglobulin deficiency, systemic immunosuppressants)
  • Use of any inhaled substance, including tobacco, marijuana, e-cigarrettes, cocaine, methamphetamines, or toxic vapors in the past 3 months or greater than 10 pack-year smoking history
  • Alcohol use disorder or greater than 7 drinks/week for women or greater than 14 drinks/week for men in the past 3 months
  • Allergy or prior adverse reaction to lidocaine, midazolam or fentanyl
  • Abnormal spirometry or electrocardiogram at time of screening
  • Pregnant (based on urine pregnancy test) or breast feeding

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERbronchoscopy with intrabronchial administration of lipopolysaccharide

The PI will administer intrabronchial LPS into the lungs of healthy volunteers and then obtaining macrophages by bronchoalveolar lavage (BAL) 24, 48, 72, 96, or 120 hours later.


Locations(1)

National Jewish Health

Denver, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03859050


Related Trials